Filter:
Because of COVID-19’s impacts on the lungs, the U.S. Alpha-1 Foundation has provided detailed, specific guidance for patients who have alpha […]
Read More… from Coronavirus: Alpha 1 Group Gives Specific Guidance for Patients
Shortly after the FDA granted an Emergency Use Authorization to its first commercially developed coronavirus test—developed by Roche for use […]
For many immunocompromised people, social distancing isn’t a new endeavor. Alpha-1 Antitrypsin Deficiency is sometimes called an “invisible disability”. This […]
https://www.alpha1.org/alphas-friends-family/resources/clinical-trials/ A clinical trial is a research study in which one or more human subjects are prospectively assigned to one […]
Recent international reports have highlighted the emergence of a new coronavirus in Wuhan, Hubei Province, China. The 2019 Novel Coronavirus […]
Read More… from 2019 Novel Coronavirus (2019-nCoV) and Plasma Protein Therapies
Miami, January 31, 2020 – The Alpha-1 Foundation is proud to celebrate its 25th Anniversary. On January 31, 1995, the […]
Read More… from The Alpha-1 Foundation celebrates its 25th anniversary
The Alpha-1 Foundation is proud to report that multinational pharmaceutical manufacturer Grifols also received approval by the Danish Medicines Council […]
Read More… from Grifols’s Prolastina approved for use in Denmark
Miami, Jan. 13, 2020 – Jonathan Maidment will return to the trails again in 2020! He is pleased to announce […]
Read More… from Jonathan Maidment goes for the Triple Crown of Hiking
Cold weather conditions can worsen symptoms for lung affected Alphas and for patients with chronic obstructive pulmonary disease (COPD), as […]
Read More… from Q&A: Alphas, seasonal flu and winter wellness
Celebrate Irish Heritage by observing St. Patrick’s Day with friends and family to benefit Alpha-1 research and programs! Enjoy the […]
